作者: Scott Richard , Robert P. Edwards
DOI: 10.1007/978-1-59745-195-6_12
关键词:
摘要: Although striking evidence exists that argues for the usefulness of hyperthermic intraperitoneal chemotherapy (HIPEC) treatment peritoneal carcinomatosis (PC), many aspects this therapy have yet to be standardized. As interest in modality increases, there are several avenues research explored. How important is cytoreductive effort, temperature elevation increment, and length time perfusion? We review what known may explored near future.